Trials / Completed
CompletedNCT02688829
The First-In-Man Pilot Study of Firehawk
The Initial Small-Scale Clinical Study of Rapamycin-Eluting Coronary Stent System of Microport (Firehawk)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a small-scale pilot clinical study of the Rapamycin-Eluting Coronary Stent System of Microport for the first time to assess the preliminary safety and feasibility used in the human body. And provide evidence for subsequent large-scale, multi-center, randomized controlled clinical trials, then provide the basis for the formal application of the product in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rapamycin target-eluting Coronary Stent System | Implantation of the rapamycin-eluting coronary stent system |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-01-01
- Completion
- 2015-01-01
- First posted
- 2016-02-23
- Last updated
- 2019-10-17
- Results posted
- 2019-10-17
Source: ClinicalTrials.gov record NCT02688829. Inclusion in this directory is not an endorsement.